Legal Implications of Cannabis Rescheduling in the U.S.
In a landmark decision, the U.S. Drug Enforcement Administration (DEA) has announced the rescheduling of cannabis from a Schedule I to a Schedule III substance under the Controlled Substances Act. This shift marks a significant milestone in the evolving legal landscape of cannabis regulation and has far-reaching implications for businesses, medical professionals, and consumers. In … Legal Implications of Cannabis Rescheduling in the U.S.